We also demonstrate that inhibiting C1GALT1 is sufficient to suppress tumor growth in vitro and in vivo, suggesting that C1GALT1 may serve as a therapeutic target for breast cancer treatment. Here, C1GALT1 is linked to breast carcinoma.